Insider Transactions Reported by 10 Insiders of ProQR Therapeutics N.V.

Symbol
PRQR on Nasdaq
Location
Leiden, Netherlands

There are no Buy or Sell transactions made by insiders since 19 Mar 2025

ProQR Therapeutics N.V. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gerardus Johannes Platenburg Chief Scientific Officer, Director $1,187,118 18 Mar 2026
Domenico Valerio Director $1,044,995 18 Mar 2026
James Samuel Shannon Director $88,614 18 Mar 2026
Theresa Heggie Director $62,817 18 Mar 2026
Dennis Hom Chief Financial Officer 18 Mar 2026
Bart Filius Director 18 Mar 2026
Martin Alexander Maier Director 18 Mar 2026
Daniel Anton de Boer Chief Executive Officer, Director 18 Mar 2026
Begona Carreno-Gomez Director 18 Mar 2026
Alison Frances Lawton Director 18 Mar 2026

Recent Insider Transactions by Companies or Individuals for ProQR Therapeutics N.V.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Domenico Valerio PRQR Ordinary Shares 0 304,963 18 Mar 2026 See footnote
Domenico Valerio PRQR Ordinary Shares 0 420,729 18 Mar 2026 Direct
Gerardus Johannes Platenburg PRQR Ordinary Shares 0 824,388 18 Mar 2026 Direct
Theresa Heggie PRQR Ordinary Shares 0 43,623 18 Mar 2026 Direct
James Samuel Shannon PRQR Ordinary Shares 0 61,538 18 Mar 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.